Theratechnologies, J&J deal

JNJ's Alza Corp. subsidiary will use its Macroflux technology to develop a transdermal formulation of a GLP-1 analog from TH. GLP-1 ( glucagon-like peptide-1), for which TH retains exclusive rights, ...